MedPath

河南永和制药有限公司

Ownership
-
Established
1997-09-10
Employees
-
Market Cap
-
Website
http://www.zzyonghe.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

202

NMPA:202

Drug Approvals

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H41022142
Approval Date
Jul 15, 2020
NMPA

Chlorpheniramine Maleate Tablets

Product Name
马来酸氯苯那敏片
Approval Number
国药准字H41022303
Approval Date
Jul 15, 2020
NMPA

Glutamic Acid Tablets

Product Name
谷氨酸片
Approval Number
国药准字H41020547
Approval Date
Jul 6, 2020
NMPA

Propranolol Hydrochloride Tablets

Product Name
盐酸普萘洛尔片
Approval Number
国药准字H41020545
Approval Date
Jul 6, 2020
NMPA

Albendazol Tablets

Product Name
阿苯达唑片
Approval Number
国药准字H41023715
Approval Date
Jul 6, 2020
NMPA

Ciprofloxacin Hydrochloride Tablets

Product Name
盐酸环丙沙星片
Approval Number
国药准字H41020996
Approval Date
Jul 6, 2020
NMPA

Furazolidone Tablets

Product Name
呋喃唑酮片
Approval Number
国药准字H41020526
Approval Date
Jul 6, 2020
NMPA

Calcium Lactate,Calciun Gluconate and Calcium Hydrogen Phosphate Chewable Tablets

Product Name
三合钙咀嚼片
Approval Number
国药准字H41024491
Approval Date
Jul 6, 2020
NMPA

Sodium Ferulate for Injection

Product Name
注射用阿魏酸钠
Approval Number
国药准字H20066619
Approval Date
Jul 6, 2020
NMPA

Aspurn Enteric-coated Tablets

Product Name
阿司匹林肠溶片
Approval Number
国药准字H41022396
Approval Date
Jul 6, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 21
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.